Emmes Group

Showing 1 posts of 1 posts found.

ILiAD Biotechnologies announces collaboration with Emmes Group on phase 3 pertussis vaccine trial

June 25, 2024
Research and Development Emmes Group, ILiAD Biotechnologies, Infections and infestations, Vaccine, whooping cough

ILiAD Biotechnologies has announced that it has selected Emmes Group to conduct the upcoming phase 3 trials of its lead …

Latest content